THE ROLE OF PROBIOTICS IN THE TREATMENT OF HELICOBACTER PYLORI INFECTION


D.S. Bordin (1, 2), Yu.V. Embutnieks (1), I.N. Voynovan (1), S.V. Kolbasnikov (2)

(1) SBHCI “Moscow Clinical Research and Practical Center” of Moscow Healthcare Department (2) FAPE SBEI HPE “Tver State Medical Academy” of RMH, Tver
Helicobacter pylori (HP) infection is one of the most common human infections, which leads to the development of chronic gastritis, gastric and duodenal ulcers, MALT-lymphoma and gastric adenocarcinoma. Increased HP resistance to previously effective schemes of eradication therapy is a source of serious concern, and requires improvement of therapeutic strategies. The literature review shows that some probiotic strains have an inhibitory effect on the HP, and their use is recommended as an addition to the standard eradication therapy that can reduce side effects and increase its effectiveness.

About the Autors


Corresponding author: D.S. Bordin – MD, Head of the Department of Pathology of the Pancreas, Biliary Tract and Upper Digestive Tract MCRPC of Moscow Healthcare Department, Professor at the Department of General Medical Practice (Family Medicine) FAPE SBEI HPE «Tver State Medical Academy» of RMH, Tver; tel. 8 (495) 304-95-51; e-mail: d.bordin@mknc.ru


Similar Articles


Бионика Медиа